Hospitals could be paid according to the quality of care and how well operations are performed, as part of efforts …
Sanofi-Aventis and Bristol-Myers Squibb are feeling the heat from a Swiss drugs company which intends to market a generic version …
Pfizer has named Garry Nicholson as head of its new global oncology unit, a venture the company believes will bring …
Merck is to slash its US sales force, making 1,200 redundant by the end of July after the FDA unexpectedly …
European industry body EFPIA has demanded 'zero tolerance' on counterfeit medicines and proposed tough new security rules to combat the …
Can biologic drugs tackle antibiotic resistance? Antibody-based products present a novel approach to the treatment and prevention of infections, as …
Sales of Lipitor dropped more than £50 million in England last year, as the blockbuster cholesterol drug fell victim to …
A new code of practice for the NHS has been launched which aims to ensure any future reforms to the …
A European Commission recommendation over a dispute between GlaxoSmithKline and Greek wholesalers spells bad news for manufacturers, according to a …
Acambis has received a $425 million, ten-year contract from the US Government agency, the Centers for Disease Control and Prevention, …
The world's first gene transplant to treat blindness, partly funded by the UK government, has successfully improved the night vision …
The European Commission is due to spend Euro 2 billion of public money to see the continent return to its …
Some specialist nurses say they are under threat of losing their jobs or being downgraded because of NHS cutbacks. The …
Calls to allow patients to contribute to the cost of NHS services, including expensive cancer treatments have been renewed.'Co-payment', where …
GlaxoSmithKline is to buy up biopharmaceutical company Sirtris, which specialises in research into the ageing process and related diseases. The …
Acambis awarded smallpox vaccine contract by US governmentAcambis has received a $425 million, ten-year contract from the US Government agency, …
Falling sales of its blockbuster flu treatment Tamiflu have dented Roche's balance sheet. The Swiss company managed sales of 10.9 …
Roche's Actemra has been given its first green light, gaining marketing approval in Japan for the treatment of rheumatoid arthritis.Actemra …